Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374(14):1356–1367. https://doi.org/10.1056/NEJMra1515442
2. Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2020) Antiemetics: ASCO guideline update. J Clin Oncol 38(24):2782–2797. https://doi.org/10.1200/jco.20.01296
3. Jordan K, Jahn F, Feyer P, Karthaus M, Leithold C, Oechsle K et al (2021) Onkopedia – Antiemese bei medikamentöser Tumortherapie. https://www.onkopedia.com/de/onkopedia/guidelines/antiemese-bei-medikamentoeser-tumortherapie/@@guideline/html/index.html#litID0EE4DI. Zugegriffen: 20. Apr. 2022
4. Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H et al (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol 10(2):115–124
5. Kitayama H (2016) Granisetron transdermal system in the management of chemotherapy-induced nausea and vomiting. Clin Med Insights Ther 8:CMT.S10240. https://doi.org/10.4137/cmt.S10240